181 related articles for article (PubMed ID: 10792091)
1. Explaining the difference in prostate cancer mortality rates between white and black men in the United States.
Merrill RM; Lyon JL
Urology; 2000 May; 55(5):730-5. PubMed ID: 10792091
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer incidence and mortality rates among white and black men.
Merrill RM; Brawley OW
Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
[TBL] [Abstract][Full Text] [Related]
3. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
4. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
5. Black-white differences in survival from late-stage prostate cancer.
Polednak AP
Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
7. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.
Polednak AP; Flannery JT
Cancer; 1992 Oct; 70(8):2152-8. PubMed ID: 1394045
[TBL] [Abstract][Full Text] [Related]
8. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
9. Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
Wilkins LJ; Tosoian JJ; Reichard CA; Sundi D; Ranasinghe W; Alam R; Schwen Z; Reddy C; Allaf M; Davis JW; Chapin BF; Ross AE; Klein EA; Nyame YA
Cancer; 2021 May; 127(9):1425-1431. PubMed ID: 33721334
[TBL] [Abstract][Full Text] [Related]
10. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
11. Stage at presentation and survival of white and black patients with prostate carcinoma.
Brawn PN; Johnson EH; Kuhl DL; Riggs MW; Speights VO; Johnson CF; Pandya PP; Lind ML; Bell NF
Cancer; 1993 Apr; 71(8):2569-73. PubMed ID: 8453581
[TBL] [Abstract][Full Text] [Related]
12. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
[TBL] [Abstract][Full Text] [Related]
13. Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004.
Robbins AS; Yin D; Parikh-Patel A
Am J Epidemiol; 2007 Jul; 166(1):71-8. PubMed ID: 17426038
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
15. Explaining racial differences in prostate cancer mortality.
Taksler GB; Keating NL; Cutler DM
Cancer; 2012 Sep; 118(17):4280-9. PubMed ID: 22246942
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
[TBL] [Abstract][Full Text] [Related]
17. The lifetime risk of developing prostate cancer in white and black men.
Merrill RM; Weed DL; Feuer EJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):763-8. PubMed ID: 9332756
[TBL] [Abstract][Full Text] [Related]
18. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
[TBL] [Abstract][Full Text] [Related]
19. Black-white differences in tumor grade (aggressiveness) at diagnosis of prostate cancer, 1992-1998.
Polednak AP
Ethn Dis; 2002; 12(4):536-40. PubMed ID: 12477140
[TBL] [Abstract][Full Text] [Related]
20. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
Eastham JA; Carver B; Katz J; Kattan MW
Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]